達華智能(002512.SZ)與南京銘朋就卡友支付股權轉讓仲裁案達成和解
格隆匯12月2日丨達華智能(002512.SZ)公佈,公司與南京銘朋信息科技有限公司(“南京銘朋”)就卡友支付服務有限公司(“卡友支付”)股權轉讓仲裁案近日達成和解,並就卡友支付股權轉讓後續事宜達成一致,簽署了《和解協議》。
相關方通過協商方式妥善解決了糾紛,該和解協議的簽訂,對公司債務危機的化解起到了一定的積極作用。後續卡友支付股權如能順利交割,則公司無需償還此次和解涉及的金額,對公司的流動性不會造成影響。目前無法判斷和解協議及協議對公司後期利潤的影響,公司將及時履行相關的信息披露義務,敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.